VPM offers tailor-made consultancy and services based on in-depth experience in development of biopharmaceutical candidates. In addition, VPM acquires promising candidates from academic research and develops them in cooperation with a pool of partners to products with a high value potential.

The company was established in August 2002 following an initiative of the German Federal Ministry of Education and Research to promote the German market by funding vaccine development. This initiative aims at establishing Germany as a leading location for vaccine research and development.